Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.
Medtronic built the Stealth AXiS system to support a wide range of surgeon preferences, clinical complexity, and care settings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results